New copper(i) complexes selective for prostate cancer cells-Reference-Cited by-同舟云学术

New copper(i) complexes selective for prostate cancer cells

Published:2020 Issue:35 Volume:49 Page:12273-12286
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Machado João Franco¹²³⁴⁵^ORCID,Sequeira Diogo⁶⁷⁸⁹¹⁰,Marques Fernanda¹¹¹²¹³¹⁴⁴^ORCID,Piedade M. Fátima M.¹⁵³⁴⁵¹⁶,Villa de Brito Maria J.¹²³⁴⁵,Helena Garcia M.¹²³⁴⁵,Fernandes Alexandra R.⁶⁷⁸⁹¹⁰^ORCID,Morais Tânia S.¹²³⁴⁵^ORCID

Affiliation:

1. CQE

2. Centro de Química Estrutural

3. Faculdade de Ciências

4. Universidade de Lisboa

5. 1749-016 Lisboa

6. UCIBIO

7. Departamento de Ciências da Vida

8. Faculdade de Ciências e Tecnologia

9. Universidade Nova de Lisboa

10. 2829-516 Caparica

11. C2TN

12. Centro de Ciências e Tecnologias Nucleares

13. Instituto Superior Técnico

14. Campus Tecnológico e Nuclear

15. Departamento de Química e Bioquímica

16. Portugal

Abstract

Synthesis of a new family of Cu(i)–phosphane complexes with N,O-heteroaromatic ligands leads to the complexes showing impressive cytotoxicity against LNCap human prostate cancer cells allied to high selectivity than against RWPE non-tumoral prostate cells.

Funder

Fundação para a Ciência e a Tecnologia

European Social Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/D0DT02157A

Reference57 articles.

1. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

2. Testicular cancer

3. Cisplatin in cancer therapy: Molecular mechanisms of action

4. P. Pedrosa , A.Carvalho , P. V.Baptista and A. R.Fernandes , Basic Concepts Viewed from Frontier in Inorganic Coordination Chemistry , IntechOpen , 2018

5. Metal Anticancer Complexes – Activity, Mechanism of Action, Future Perspectives

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis: Mechanism, role, and advances in urological malignancies;Medicinal Research Reviews;2024-02

2. Cu-related agents for cancer therapies;Coordination Chemistry Reviews;2023-07

3. Copper(I)‐Thiosemicarbazone Complexes with Dual Anticancer and Antiparasitic Activity;ChemMedChem;2023-05-05

4. Hydrazylpyridine salicylaldehyde–copper(ii)–1,10-phenanthroline complexes as potential anticancer agents: synthesis, characterization and anticancer evaluation;Dalton Transactions;2023

5. Synthesis and Anti-Cancer Investigations of Novel Copper(II) Complexes Based on Adenine;2023